| Followers | 48 |
| Posts | 1829 |
| Boards Moderated | 0 |
| Alias Born | 02/12/2022 |
Recent NDRA News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:10:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:29:26 PM
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/31/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 01:21:26 PM
- ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 03/25/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 02:48:01 AM
- ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:04 AM
- ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use • Business Wire • 12/04/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 09:23:04 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 11/26/2025 01:30:32 PM
- ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker • Business Wire • 11/20/2025 01:00:00 PM
- ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results • Business Wire • 11/17/2025 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2025 09:38:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 09:27:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:24:12 PM
- ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA • Business Wire • 11/13/2025 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/06/2025 10:00:59 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/28/2025 10:43:58 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/28/2025 11:10:18 AM
